Author: toker

At Boise Hempfest, supporters rally for a medical cannabis initiative

Source link

Best CBD Products of 2026: Top CBD Oil, Gummies & THC-Free Options Reviewed

Some of the highest-rated CBD products promise everything from pain relief and better sleep to everyday well-being. But with so many CBD options on …

Read more

Source link

SRWMD says cannabis plant in Jefferson County violated environmental resource permit

Source link

It Took a Text From Joe Rogan. Now Psychedelics Are a Federal Research Priority.

President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million to ibogaine research. The psychedelics community is cautiously optimistic, and watching closely.

President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate research into psychedelic therapies and allocating $50 million for ibogaine research. The signing took place in the Oval Office on April 18, with Health and Human Services Secretary Robert F. Kennedy Jr., podcast host Joe Rogan, veterans advocate Marcus Luttrell and Representative Morgan Luttrell among those present.

“I’m pleased to announce historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs,” Trump said at the signing, as reported by The New York Times. Of ibogaine specifically, Trump added: “I never heard anything about it in the past. It was almost like, taboo. It’s not taboo anymore.”

FDA Commissioner Dr. Marty Makary said decisions on the drugs could come as soon as this summer, telling those assembled that drugs aligned with national priorities could get approved “in weeks, not a year or a year-plus,” according to CNN.

How Joe Rogan helped make this happen

Rogan, who backed Trump in 2024 and has devoted significant airtime to advocates for ibogaine’s use in treating veterans, described the moment from the Oval Office. He said he had sent Trump information about ibogaine, and that the response came back almost immediately: “Sounds great, do you want FDA approval? Let’s do it.” Rogan called it “literally that quick.”

What the order actually does

The executive order covers ibogaine by name but extends to LSD, MDMA, psilocybin and other psychedelic compounds. According to Reuters, federal officials said the reforms would pave the way for the reclassification of these substances following successful clinical trials. The $50 million in federal funding will most immediately benefit Texas, which had already committed $50 million of its own to ibogaine research but recently failed to secure matching funds from a private drug developer.

Veterans at the center of the push

The signing was flanked by veterans advocates, including Marcus Luttrell and his brother, Representative Morgan Luttrell, a Texas Republican. Representative Michael McCaul joined Luttrell in vowing to pursue legislation to make the changes more durable. “We will continue working in Congress to build on the president’s leadership and expand access to this life-saving treatment,” the two said in a joint statement. “Our veterans answered the call for us. Now we must deliver for them.”

Ibogaine has drawn particular attention from veteran groups because of its reported efficacy in treating PTSD and opioid use disorder. Mexico currently has ibogaine treatment centers that have long attracted U.S. veterans who cannot legally access the treatment at home.

MAPS: opportunity and responsibility

The Multidisciplinary Association for Psychedelic Studies, which has been conducting ibogaine research for over a decade, welcomed the executive order while stressing that speed cannot come at the expense of rigor.

“As federal agencies are directed to reduce barriers to clinical research and accelerate drug approvals for psychedelic substances, it is critical that these efforts remain grounded in transparent, evidence-based processes,” said Ismail L. Ali, J.D., co-executive director of MAPS. He noted that MAPS will publish a publicly available Investigator’s Brochure for ibogaine this summer, providing a comprehensive literature review of the compound’s known clinical and non-clinical data.

Ali also raised a critical concern about supply: because iboga is a limited natural resource, mass production of ibogaine carries real risks for the people, traditions and land where iboga is grown in Gabon. “As it is incorporated into medicine, we call for alignment with global public health principles, including cultural respect, sustainability, and community engagement,” he said.

“People living with addiction and trauma deserve our urgent attention, not just incremental change. We have both an opportunity and a responsibility.”

Betty Aldworth, Co-Executive Director, MAPS

Betty Aldworth, MAPS’s other co-executive director, was blunt about the stakes. “Today, people desperate for healing are traveling abroad or self-medicating with impure substances and little support,” she said, adding that acceleration of approval timelines must be paired with regulated access, provider training and robust insurance coverage. “When we ignore that evidence, we put our communities and future at risk.”

The clinical perspective

Tom Feegel, CEO of Beond, a clinical neurohealth center focused on ibogaine-assisted protocols, called the order a historic inflection point, though he emphasized that execution is everything.

“The opportunity now is not hype — it is execution: rigorous science, disciplined safety standards, physician-led protocols, and real-world outcomes data.”

Tom Feegel, CEO, Beond

“Ibogaine is not a conventional intervention,” Feegel said. “It works at the level of brain chemistry and neural signaling, opening a window of neuroplasticity where meaningful change becomes possible when guided by the right advanced clinical frameworks.” He stressed that ibogaine must be delivered in medically supervised environments with cardiac monitoring, careful screening and therapeutic integration, not as a standalone treatment.

The science and the caution

Ibogaine remains a Schedule I controlled substance in the United States. Early research, including a Stanford observational study on 30 special forces veterans, showed significant reductions in PTSD, depression and anxiety symptoms. But the compound carries real cardiac risks, including abnormal heart rhythms, and several deaths have been associated with its ingestion, though causation is not always definitively established.

Psilocybin and LSD have both received FDA breakthrough therapy designation in recent years. MDMA was declined by the FDA in 2024 for PTSD treatment, pending additional clinical trials after concerns were raised about the integrity of prior studies.

Scientists have expressed concern that the administration’s emphasis on speed could lead to bypassing rigorous research benchmarks and put patients at risk, according to CNN’s reporting.

Part of a broader pattern, with an important caveat

This is Trump’s second psychedelic-adjacent executive order in four months. In December 2025, he directed the attorney general to move forward with reclassifying cannabis from Schedule I to Schedule III. The DEA has still not completed that reclassification. Executive orders direct agency action but do not guarantee it.

Whether this order moves faster than the cannabis rescheduling directive will depend entirely on follow-through from the FDA and DEA. The FDA Commissioner’s promise of decisions “in weeks” will be watched closely by researchers, veterans, operators and the broader psychedelics community.

The bipartisan resonance of Saturday’s signing is real and notable. Representative Lou Correa, a California Democrat, applauded the action publicly. Rogan, who has been openly critical of some of Trump’s other policies, was present and credited. That unusual alignment may give the order more political durability than it would otherwise have.

<p>The post It Took a Text From Joe Rogan. Now Psychedelics Are a Federal Research Priority. first appeared on High Times.</p>

Source link

Ohio Judge Temporarily Pauses Hemp Product Ban For Two Businesses

Source link

Cannabis Gummies: A Complete Guide to Edibles and Effects

Have you ever wondered why many people choose cannabis gummies instead of other forms? These small treats look simple, but they work in a unique way inside the body. Unlike smoking, edibles take time to show effects, which can surprise beginners. That is why learning the basics is important before trying them. In this guide, […]

The post Cannabis Gummies: A Complete Guide to Edibles and Effects appeared first on Stoner | Pictures | Stoners Clothing | Blog | StonerDays.

Source link

What Is CBD? Benefits, Side Effects, and What the Research Actually Says

What Is CBD? CBD stands for cannabidiol. It’s one of more than 100 naturally occurring compounds found in the cannabis plant, belonging to a family called cannabinoids. Unlike THC — the compound responsible for cannabis’s intoxicating effects — CBD does not get you high. It doesn’t produce euphoria, impair your coordination, or alter your perception […]

Source link

Cannabis firms focus on reforms beyond CCC overhaul

Source link

CBD, delta-9, and hemp THCA 420 deals to make the most of the big day

From gummies, sips, and fast-acting shooters, we’ve rounded up great deals, limited drops, bundles, and standout products to help you celebrate the big day.

The post CBD, delta-9, and hemp THCA 420 deals to make the most of the big day appeared first on Leafly.

Source link

Cheech Marin Is Talking to Sandwiches in a Jimmy John’s Ad. Cannabis Culture Has Officially Gone Mainstream.

Jimmy John’s Dream Rotation campaign doesn’t wink at cannabis culture. It hires Cheech Marin, lets him argue with a sandwich and makes Kal Penn’s ideal 4/20 a gym session and a book. The wall is down.

Cheech Marin is sitting, holding a sandwich. He looks at it the way a man looks at something he has decided to tolerate. “I try to like people,” he says, “but then they start talking.”

The sandwich grows a face and starts talking.

View this post on Instagram

A post shared by Jimmy John's (@jimmyjohns)

This is a Jimmy John’s ad. It is also, somehow, the most accurate representation of where cannabis culture and mainstream America currently stand: fully in the same room, no longer pretending otherwise, and apparently ready to get weird about it.

The Dream Rotation campaign, which Jimmy John’s launched this week ahead of 4/20, is built around a simple and genuinely funny idea. The brand tapped a handful of celebrities known to partake, asked each of them for their ideal post-session meal, filmed the results and let the creative get strange. The lineup includes Cheech Marin, Kal Penn, Amanda Batula and Skylar Gisondo. Each has their own spot. Each brings their own energy. Together, they amount to something the cannabis world has not seen from a brand this size in quite this way before.

This is not a wink. This is not a green leaf emoji in a caption. This is Cheech Marin, one-half of the most iconic cannabis comedy duo in film history, having a full argument with a sentient sandwich on behalf of a national fast food chain.

The Cast Matters

The talent selection is doing real work here and it is worth slowing down on.

Cheech Marin is not a celebrity who happens to be adjacent to cannabis. He is, alongside Tommy Chong, the defining pop culture face of cannabis humor in America. Casting him is not a subtle nod. It is a statement.

Kal Penn is Harold of Harold & Kumar, the film franchise that brought stoner comedy into a new generation and a new demographic. He later served in the Obama White House, which gives him a cultural biography that almost no one else in the entertainment industry has. His presence in the campaign adds a layer the other talent cannot: the idea that cannabis and mainstream American institutions are not actually that far apart.

Skylar Gisondo, who appears in a series of memes Jimmy John’s has been posting alongside the campaign, brings the younger internet-native energy. His face sipping through a straw while captions read “me when my grandma asks me to garden with her” and “me when the sweet treat demon starts whispering in my ear” is the kind of content that travels. The “gardening” euphemism, deployed without explanation, assumes the audience is in on the joke. They are.

View this post on Instagram

A post shared by Jimmy John's (@jimmyjohns)

The Orders Are the Bit

Part of what makes the campaign work is that the celebrity meal orders are genuinely specific in a way that feels real rather than manufactured.

Kal Penn ordered a toasted Beach Club, no cheese, horseradish sauce, salt and vinegar chips, and the new Cereal n’ Milk Crispy Treat. His described eating ritual involves alternating between chips and sandwich in a precise sequence, with the dessert distributed across both halves. This is not a man who casually threw out a sandwich order. This is a man with a system.

Cheech went with the Italian Night Club and salt and vinegar chips. He also picked Penn as his dream session partner, a choice that connects two of the most culturally significant cannabis films ever made in one meal order.

Amanda Batula took the J.J.B.L.T. with BBQ chips. Skylar Gisondo ordered the Spicy East Coast Italian, no mayo, with jalapeño chips.

The specificity is the joke and also the point. These are not sanitized celebrity endorsements. They are actual people with actual preferences, talking about getting stoned and eating sandwiches, on camera, for a brand with thousands of locations across the country.

What This Actually Means

For most of the last decade, mainstream brands approaching 4/20 fell into one of two categories. The first was the safe play: a vague post, a color palette that happened to include green, a caption that could plausibly mean anything. The second was the slightly bolder play: a joke that gestured toward cannabis without committing to it, often involving the number 420 placed somewhere in the content and nothing else.

Jimmy John’s did neither. The Dream Rotation campaign names what it is, casts people whose entire cultural identity is built around cannabis, films Cheech Marin being existentially annoyed by a talking sandwich and deploys Skylar Gisondo memes that use stoner slang as fluently as any dedicated cannabis brand would.

The reason this is possible now and was not in quite the same way five years ago is not complicated. Legal adult-use cannabis exists in the majority of American states. The cultural stigma has collapsed faster than the federal policy has moved. Brands that once worried about alienating customers by associating with cannabis now risk appearing out of touch by refusing to acknowledge what their customers already do.

Jimmy John’s read the room. The room, it turns out, is full of people who have opinions about chip-to-sandwich ratios and find it very funny when Cheech Marin loses an argument to his lunch.

<p>The post Cheech Marin Is Talking to Sandwiches in a Jimmy John’s Ad. Cannabis Culture Has Officially Gone Mainstream. first appeared on High Times.</p>

Source link